ChenGuang Biotech Group Co., Ltd. (SHE:300138)
China flag China · Delayed Price · Currency is CNY
14.10
+0.41 (2.99%)
At close: Mar 6, 2026

ChenGuang Biotech Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
94.05479.72434.03351.51
Depreciation & Amortization
166.5152.83144.85130.74
Other Amortization
0.650.20.90.2
Loss (Gain) From Sale of Assets
-4.890.63-1.08-0.1
Asset Writedown & Restructuring Costs
0.461.11.3210.91
Loss (Gain) From Sale of Investments
-12.68-74.02-33.45-30.93
Provision & Write-off of Bad Debts
0.110.870.77-1.93
Other Operating Activities
197.1980.74100.2574.9
Change in Accounts Receivable
62.07135.24-274.17-119.09
Change in Inventory
-670.57-1,145187.13-435.93
Change in Accounts Payable
-41.67-211.8176.3190
Operating Cash Flow
-222.81-588.47734.8163.9
Operating Cash Flow Growth
--1049.93%-87.93%
Capital Expenditures
-149.54-189.2-176.03-280.82
Sale of Property, Plant & Equipment
0.020.280.423.58
Investment in Securities
-315.58-336.91-540.91-
Other Investing Activities
24.1577.5620.1212.47
Investing Cash Flow
-440.95-448.27-696.4-264.76
Long-Term Debt Issued
5,7834,6783,5112,081
Total Debt Issued
5,7834,6783,5112,081
Long-Term Debt Repaid
-5,088-3,381-3,132-1,278
Total Debt Repaid
-5,088-3,381-3,132-1,278
Net Debt Issued (Repaid)
695.81,297378.58803.12
Repurchase of Common Stock
-396.53-95.84--
Common Dividends Paid
-174.05-181.41-143.98-109.77
Other Financing Activities
-21.41276.95-195.55-152.39
Financing Cash Flow
103.81,29739.05540.96
Foreign Exchange Rate Adjustments
-10.49-6.05-4.94-4.36
Net Cash Flow
-570.46254.0372.51335.75
Free Cash Flow
-372.35-777.67558.78-216.92
Free Cash Flow Margin
-5.32%-11.32%8.88%-4.45%
Free Cash Flow Per Share
-0.72-1.461.05-0.41
Cash Income Tax Paid
7.269.45-46.55-31.36
Levered Free Cash Flow
39.79-997.32-131.42-423.74
Unlevered Free Cash Flow
111.3-945.13-89.42-390.52
Change in Working Capital
-664.21-1,23187.21-471.4
Source: S&P Global Market Intelligence. Standard template. Financial Sources.